Webinar Title: "Using advance proteomics biomarker approaches to better understand Rare Human Disease and COVID-19"
We would like to invite you to Olink webinar event at 13:00 CEST on Tuesday 24th May 2022, "Using advance proteomics biomarker approaches to better understand Rare human disease and COVID-19".
We have a great line speakers that will present how the use of next-generation affinity proteomics provided insights within an omics approach in rare disease cohorts and challenges of small numbers of patients.
Also the session will cover several studies using Olink technology that identify the most robust protein markers for the disease and underlying pathways relevant in different conditions, as well as how for COVID-19, differentially expressed protein biomarkers in the plasma of severe COVID-19 patients. These are implicated in the pathogenesis of COVID-19 and present targets for candidate drugs to prevent or treat severe complications.
Speakers
Dr Stefan Nierkens
Medical Immunologist, Center for Translational Immunology, University Medical Center Utrecht
"Omics Approach in Rare Disease and the Challenge of Small Numbers of Patients"
Dr Frank Schmidt
Associated Professor of Biochemistry and Director of the Proteomics Core of Weill Cornell Medicine in Qatar
"The use of the Olink technique in various studies on COVID-19: A way to better understand the disease"
Houari Abdesselem, PhD
Manager, Proteomics Core Facility, Qatar Biomedical Research Institute, Hamad Bin Khalifa University
"Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications"